Final results of CA180-372/COG AALL1122 phase 2 trial of dasatinib and chemotherapy in pediatric patients with newly-diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (PH plus ALL)
Authors
Hunger, S.Saha, Vaskar
Devidas, M.
Valsecchi, M.
Gastier-Foster, J.
Cazzaniga, G.
Reshmi, S.
Borowitz, M.
Moorman, A.
Heerema, N.
Carroll, A.
Swanink, R.
Martin, P.
Loh, M.
Raetz, E.
Schultz, K.
Slayton, W.
Schrappe, M.
Silverman, L.
Biondi, A.
Affiliation
Children’s hospital of Philadelphia, Pediatric Oncology, Philadelphia, United States of AmericaIssue Date
2020